|
⚲
|
| Keyboard |
| Thomas John B
✚
|
|
|---|---|
| CIK # | 0001641587 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001641587] | |
| 4 | [0001641587] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Thomas John B | |
| Horizon Therapeutics Public Ltd Co |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Horizon Therapeutics Public Ltd Co HZNP
Ordinary Shares
|
2016-05-06 | Option exercise | 9,375 | ||
|
Horizon Therapeutics Public Ltd Co HZNP
Ordinary Shares
|
2016-05-06 | Tax withheld | 2,916 | $13.41 | 39,104 |
|
Horizon Therapeutics Public Ltd Co HZNP
Restricted Stock Units · derivative
|
2016-05-06 | Option exercise | 9,375 | $0.00 | |
|
Horizon Therapeutics Public Ltd Co HZNP
Stock Option (Right to Buy) · derivative
|
2015-05-06 | Grant | 83,000 | $0.00 | |
|
Horizon Therapeutics Public Ltd Co HZNP
Performance Share Units (PSU) · derivative
|
2015-05-06 | Grant | 450,000 | $0.00 | |
|
Horizon Therapeutics Public Ltd Co HZNP
Restricted Stock Units · derivative
|
2015-05-06 | Grant | 37,500 | $0.00 | |
|
Horizon Therapeutics Public Ltd Co HZNP
Performance Share Units (PSU) · derivative
|
2015-05-06 | Grant | 150,000 | $0.00 |